Skip to content
healthcare.dev
Get a free key

Gazyva

NDC 50242-070, obinutuzumab, injection, solution, concentrate, from Genentech, Inc..

Product NDC
50242-070
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125486
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-070 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OBINUTUZUMAB1000 mg/40mL

Pharmacologic classes

CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
50242-070-01502420070011 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) / 40 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-070

Use it

Look up 50242-070 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-070 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.